Recent Headlines
Within Biotechnology
Trevigen Announces a Highly Sensitive, Fluorescent, One Hour PARP Inhibition Assay
Until now, commercially available PARP assay kits required multiple steps and were time consuming. Trevigen overcomes these drawbacks with the release of the HT Fluorescent Homogeneous PARP Inhibition Assay. - June 22, 2008 - Trevigen, Inc.
Xcelience Strengthens Development Services with Addition to Executive Team
The formulation development company’s services are led by an industry pioneer. - June 22, 2008 - Xcelience, LLC
Colorado’s Bioscience Community Celebrates the State’s Largest Medical Device Manufacturer
Gambro BCT, Inc., (to be CaridianBCT, Inc., as of July 14) is the largest medical device manufacturer headquartered in Colorado, with worldwide revenues approaching $500M and 2300 employees. The company had previously been a subsidiary of Gambro AB, a publicly traded, multinational healthcare company based in Sweden. The name CaridianBCT combines two words “care” and “meridian” to highlight the manufacturer's commitment to care and global reach. - June 20, 2008 - Colorado BioScience Association
AnaSpec Offers Custom Synthesis of Hydrocarbon-Stapled Peptides
The innovative technique of hydrocarbon stapling in peptides is introducing valuable new functionality to peptide-related research. AnaSpec is pleased to offer custom synthesis for hydrocarbon-stapled peptides. Hydrocarbon-stapled peptides are peptides capable of forming stable alpha helical... - June 20, 2008 - AnaSpec, EGT Group
Anavex Further Strengthens Board of Directors
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) today announced the appointment of David L. Tousley, CPA, MBA, to its Board of Directors. Mr. Tousley is an accomplished professional with many years of experience as a senior financial and operations executive in start-up and... - June 20, 2008 - Anavex Life Sciences Corp.
New Anti-CARMA Antibody Series Released by AnaSpec
AnaSpec has introduced a new series of IHC validated antibodies, Anti-CARMA/CARD/Bimp antibodies. CARMA proteins are scaffold molecules that belong to the membrane-associated guanylate kinase-like (MAGUK) and the caspase-associated recruitment domain (CARD) protein families. They play critical... - June 19, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Eleven New Peptides
This week AnaSpec, a world leader in custom and catalog peptides, introduced eleven (11) new peptides. - June 18, 2008 - AnaSpec, EGT Group
Device Surpasses Steroids in Strength and Overall Athletic Performance Enhancement
A new episode of Super Human Radio® reveals real-life results in world ranked athletes using a new nighttime technique for improving strength, stamina, physical and mental performance while providing deep, recuperative sleep. - June 15, 2008 - EarthPulse Tech, LLC
Baxa Corporation Launches PACT™ Product Line at the ASHP Summer Meeting
Baxa is promoting its new PACT (Productivity and Compliance Tools) product line at the American Society of Health-System Pharmacists 2008 Summer Meeting and Exhibition beginning today at the Washington State Convention and Trade Center in Seattle. The PACT line includes products and services designed to help pharmacies improve patient-care efficiencies and simplify compliance with state and federal regulations. - June 09, 2008 - Baxa Corporation
Trevigen Announces the Release of Four New Assay Kits for 3-D Cell Proliferation
Trevigen introduces four new 3-D cell proliferation kits, including a core kit and three different kits containing basement membrane extract, laminin I, and collagen I. These are the first standardized kits engineered for assessing the effects of compounds or genetic alteration on cell proliferation in 3-D culture. - June 07, 2008 - Trevigen, Inc.
Baxa Corporation Named Finalist for Third Year as a Best Company to Work For in Colorado
Englewood-based Baxa Corporation has been named a finalist in the 3rd Annual Best Companies to Work for in Colorado competition. This is the company’s third consecutive year as a finalist in the large company category. - June 05, 2008 - Baxa Corporation
Clinical Trials in Russia. 1st Quarter 2008
On June 2, 2008 Synergy Research Group (SynRG), a Russia-based CRO, presented the current issue of its Orange Paper, a regular analytical report on the market of clinical trials in Russia. According to the report The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (alias RosZdravNadzor, RZN) approved 130 new clinical trials in Russia in Q1 2008. - June 04, 2008 - Synergy Research Group
Baxa Launches New Microsite for STAR Center Training Facility
Baxa announces the launch of a new and improved microsite featuring enhanced course registration and an interactive tour of its STAR (Skills Training, Academics and Resources) Center training facility. Visitors to the new STAR Center interactive microsite can view instructor biographies, tour the entire facility online, register for current and future classes and download all course information. - June 02, 2008 - Baxa Corporation
Genomic Nanosystems Announced Today That It Has Received the Exclusive Patent Rights for Clonal Amplification and Digital PCR (Polymerase Chain Reaction) from Cytonix
Genomic Nanosystems, LLC has received the exclusive patent rights to U.S. patent No. 6,143,496. Patent ‘496 was first to describe methods for detecting single nucleic acid molecules after one amplification step, for amplifying one or more nucleic acids in nano-scale volumes or regions, and for carrying out digital PCR. - June 01, 2008 - Genomic Nanosystems
New SensoLyte™ 520 Cathepsin S Assay Kit Introduced by AnaSpec
AnaSpec has introduced the SensoLyte™ 520 Cathepsin S Assay Kit to its broad collection of long wavelength FRET protease assay kits. - May 29, 2008 - AnaSpec, EGT Group
AnaSpec Introduces Sixty New Peptides & 3 New Assay Kits
This week, AnaSpec introduced sixty (60) new catalog peptides and three (3) new assay kits. - May 27, 2008 - AnaSpec, EGT Group
Xcelience and Its CEO Are Finalists for Three Prestigious Business Awards
The Tampa-based CRO and its chief executive are voted as best company and CEO of the year. - May 26, 2008 - Xcelience, LLC
Colorado Governor Bill Ritter to Attend 2008 BIO Conference and Expo, Marketing The State’s Bioscience Sector to 20,000 Industry Executives
Colorado Governor Bill Ritter will attend BIO 2008 in San Diego, California, June 18, 2008, marketing the State’s bioscience sector to more than 20,000 bioscience company executives, researchers, economic development agencies and service providers attending the four-day event. A Colorado Pavilion (Booth #3049), on the trade show floor, will feature the state’s research institutions and highlight Colorado’s support for bioscience companies and its business-friendly environment. - May 24, 2008 - Colorado BioScience Association
AnaSpec Introduces 8 New Antibody Products
AnaSpec added eight (8) new antibody products to its growing collection. - May 24, 2008 - AnaSpec, EGT Group
Trevigen Releases the First Standardized 3-D Culture Cell Harvesting Kit
Trevigen releases the first standardized kit for isolating cells from 3-D Culture for biochemical analysis. The Cultrex® 3-D Culture Cell Haversting Kit is based on a nonenzymatic approach which prevents biochemical degradation during processing and overcomes the problems associated with extracting cells from BME or Laminin I in 3-D Culture. - May 24, 2008 - Trevigen, Inc.
Trace Contaminant Detection by Ultraviolet Microscopy and Microspectroscopy
Detection and analysis of trace organic and inorganic contaminants on precision devices by ultraviolet microscopy and microspectroscopy. - May 23, 2008 - CRAIC Technologies, Inc.
Anavex Announces Appointment of Oncology Specialist to Board of Directors, Changes to Executive Management
Anavex Life Sciences Corp. ("ANAVEX'') (OTC BB:AVXL.OB) today announced the appointment of Alison Ayers to its Board of Directors. Ms. Ayers is currently the Worldwide Commercial Head for Oncology at Pfizer, with responsibility for Pfizer's oncology portfolio, which includes more than 20 drug... - May 23, 2008 - Anavex Life Sciences Corp.
Baxa Web Site and Environmental Stewardship Programs Selected as Finalists for the Sixth Annual American Business Awards National Competition
Baxa Corporation announces its selection as a finalist in two categories for the 2008 American Business Awards. The company was chosen for Best Web Site and Best Corporate Environmental Responsibility Program. The American Business Awards recognize excellence at all levels of business – from management and sales to marketing and communications activities. Hailed as “the business world’s version of the Oscars,” The American Business Awards are the only national, all-encompassing awards program. - May 19, 2008 - Baxa Corporation
AnaSpec Introduces ClearPoint™ Heavy Isotope-Labeled Peptides
AnaSpec has introduced ClearPoint™ Peptides, heavy isotope-labeled peptides for absolute quantitation (AQUA) of proteins. - May 18, 2008 - AnaSpec, EGT Group
Baxa PadLock® Product Launch Wins Colorado BMA Best Strategy Distinction & Gold Key Campaign Award
Baxa Corporation has won two Colorado Business Marketing Association Awards for its integrated direct mail campaign featuring the PadLock® Set-Saver product – Best Strategy and Gold Key for Best B2B campaign (less than $50,000.) The campaign focused on the product’s features and benefits while providing a variety of different components for raising customer interest and awareness and promoting Baxa to this new market – IV nurses. - May 15, 2008 - Baxa Corporation
Lack of Sleep Affects Blood Sugar Insulin and Appetite Faster Than Previously Thought
Sleep polls around the world continue to indicate people of all ages are sleeping less well while Incidence of type 2 diabetes has reached epidemic proportions. For the first time in history, children are being diagnosed with adult onset diabetes. New research strongly suggests the mechanism causing poor sleep and how quickly poor sleep detrimentally affects appetite, blood sugar, insulin, and weight gain. - May 14, 2008 - EarthPulse Tech, LLC
Xcelience Launches New Service to Enhance Its Preformulation & Formulation Capabilities
The Tampa-based CRO continues its perpetual growth with new XRD support. - May 08, 2008 - Xcelience, LLC
Baxa Corporation Features PadLock®Set Saver at the Infusion Nurses Society Annual Meeting in Phoenix, AZ
Baxa is promoting its new PadLock Set Saver product at the Infusion Nurses Society 35th Anniversary Annual Meeting and Industrial Exhibition beginning today at the Phoenix Convention Center in Phoenix, Arizona. PadLock provides a secure seal for the end of the administration set, preventing contamination when the set is not being used for infusion. The Baxa sales team will demonstrate the new device at booth #420. - May 05, 2008 - Baxa Corporation
Colorado BioScience Association Announces Nine New Board Members
Nine new board members have been elected to the Colorado BioScience Association (CBSA) 40-member Board of Directors. In related action, seven existing members were elected to reappointments on the CBSA board this year. CBSA, with more than 400 members, is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. - May 04, 2008 - Colorado BioScience Association
AnaSpec’s Published References Passes 600
The number of published papers that cite AnaSpec’s products has passed 600. - May 04, 2008 - AnaSpec, EGT Group
Baxa Announces Colorado BioScience Association Sponsorship
Baxa Corporation recognizes the work of the Colorado Bioscience Association (CBSA) on behalf of the Colorado medical device industry through a corporate sponsorship for 2008. Through the years, Baxa has provided support for CBSA events and activities without a formal sponsorship grant. The company’s investment underlines its support of CBSA initiatives for industry growth, networking and professional education. - May 03, 2008 - Baxa Corporation
AnaSpec Presents Fluorimetric TACE Detection Poster at SBS Conference
AnaSpec presented its latest findings in regards to the detection of TACE activity using FRET technology. - May 03, 2008 - AnaSpec, EGT Group
Baxa Launches Microsite Featuring the MedBoard™ Medication Tracking System
Baxa announces the launch of a microsite dedicated to its MedBoard Medication Tracking System featuring enhanced product information and interactive demonstration tools. Customers can use the site’s interactive tools to explore MedBoard features and benefits, as well as download documents covering frequently asked questions and key product attributes. - May 02, 2008 - Baxa Corporation
Colorado Rep. Bernie Buescher Keynotes the CBSA Annual All-Member Meeting
Representative Bernie Buescher (D-Grand Junction), Chairman of the Colorado General Assembly’s Joint Budget Committee (JBC), provided the keynote address at the Colorado BioScience Association (CBSA) Annual All-Member Meeting yesterday at the University Club in Denver. In other action, 2008 association sponsors were announced, plus new and reappointed board members voted on by those in attendance. - April 30, 2008 - Colorado BioScience Association
AnaSpec Introduces a Suite of Phospho-Specific Anti-Her2 Antibodies
AnaSpec has introduced a full suite of phospho-specific ErbB-2 (Her-2) polyclonal antibodies. - April 30, 2008 - AnaSpec, EGT Group
Colorado BioScience Association Praises Governor Ritter’s Signing and Rep. Riesberg and Sen. Bacon’s Sponsorship of the Bioscience Research Grant Program (HB 1001)
Colorado Governor Bill Ritter has signed HB 1001, spurring development of the bioscience industry in Colorado. The Bioscience Research Grant Program puts $26.5 million over the next five years into several initiatives within Colorado’s bioscience industry. These funds and program will be managed by the Colorado Office of Economic Development and International Trade. - April 26, 2008 - Colorado BioScience Association
AnaSpec Introduces 13 New Antibody Products
AnaSpec added thirteen (13) new antibody products to its growing collection. - April 25, 2008 - AnaSpec, EGT Group
New Mike Hurst Article Available at Expert411.com Examines How to Prevent Infection from IV Therapy Complications, Including Nursing Perspective
Healthcare-associated infections are a staggering cause of increased provider costs and morbidity in the United States; and intravenous therapy complications are a major contributor to bloodstream infections. A new Mike Hurst-bylined article is now posted at the “Expert Information for Journalists” site about this topic. Hurst reviews the problem and gives perspective to what nurses surveyed know and believe about IV therapy complications. - April 24, 2008 - Baxa Corporation
SensoLyte™ MMP Assay Kits Offer a New Industry Standard for Sensitivity
AnaSpec’s SensoLyte™ line of MMP assay kits have quickly become the new standard in MMP assay sensitivity. - April 24, 2008 - AnaSpec, EGT Group
AnaSpec FRET-Based MMP Substrates Used in Double Differential in Vivo Zymography
AnaSpec FRET-based MMP substrates were recently used in a double differential in vivo zymography study at the University of New Brunswick. - April 23, 2008 - AnaSpec, EGT Group
Baxa Environmental Program Nets Significant Results
In celebration of Earth Day tomorrow, Baxa Corporation announces significant increase in environmental benefits through environmental stewardship and recycling programs. Baxa is committed to manufacturing operations that minimize the opportunity for environmental harm and support sustainable resources. - April 21, 2008 - Baxa Corporation
New Anti-MMP Antibodies Introduced by AnaSpec
AnaSpec has introduced its newest MMP antibodies. - April 11, 2008 - AnaSpec, EGT Group
Plymouth Pharmaceuticals and Dermatologist Cited in ‘Skin and Allergy News’ Regarding Drug’s (Acunol™) Role in Preventing Jewelry Allergy
The respected journal “Skin & Allergy News” recently released “Nickel Named Contact Allergen of the Year” in its current issue. Researcher Dr Katherine A Zug, of the Department of Dermatology at Dartmouth Hitchcock Medical Center in Lebanon, NH, has published her... - April 10, 2008 - Plymouth Pharmaceuticals Inc
"USP Chapter 797: Understanding the Revisions” Technical Paper by Baxa Corporation’s Mike Hurst Now Accessible on Expert411.com for Media and Professional Reference
The “USP Chapter 797: Understanding the Revisions” technical paper, authored by Baxa Corporation’s Mike Hurst, RPh, MBA, is now accessible at Expert411.com for media and professional reference. USP Chapter 797 became official on January 1, 2004. The first major revision was released on December 3, 2007, following years of soliciting feedback and the review of hundreds of responses by the USP Sterile Compounding Committee. June 1, 2008 is the effective date for the new standards. - March 31, 2008 - Baxa Corporation
AnaSpec Offers Fluo-3 - a High Affinity Fluorescent Calcium Indicator
Calcium plays a vital role in the specific and selective regulation of major cellular processes and is central in the regulation of cardiac contractility, growth and gene expression. Calcium indicators are small molecules that can respond to the binding of Ca2+ ions by changing their spectral... - March 29, 2008 - AnaSpec, EGT Group
Trevigen Launches LDEV Free Basement Membrane Extract
Trevigen launches LDVE Free Basement Membrane Extract within its Cultrex® product line of Cell Differentiation and Angiogenesis products. Basement Membrane Extract (BME) can be used for promotion and maintenance of a differentiated phenotype in a variety of cell cultures including primary... - March 29, 2008 - Trevigen, Inc.
Baxa Corporation Launches Call for Research Papers
Baxa to offer unrestricted educational grants for research studies on the usage and benefits of the new PadLock® Set Saver. Grants will be awarded for research intended for presentation at the INS, AVA, APIC or similar meetings and/or publication in the Journal of Infusion Nursing, Journal of Vascular Access, American Journal of Infection Control or similar publications. - March 28, 2008 - Baxa Corporation
Avanti Therapeutics Launches Chikujee Therapeutics, a Targeted Drug Delivery Company
Avanti Therapeutics, a privately held biopharmaceutical company, said it has incubated and launched a new bionanotechnology company for targeted drug delivery called Chikujee Therapeutics. Chikujee Therapeutics hopes to commercialize nanomedicines using its proprietary, cell specific targeted drug... - March 28, 2008 - Chikujee Therapeutics
AnaSpec Introduces Suite of Labeled & Unlabeled Anti-Actin Antibodies
AnaSpec has introduced a suite of labeled and unlabeled anti-Actin antibodies. - March 26, 2008 - AnaSpec, EGT Group
AnaSpec Introduces New Technical Support Solution
This month AnaSpec introduced a significantly improved online technical support resource for its website users. AnaSpec's new Frequently Asked Questions (FAQ) Page now offers a searchable database of solutions that offers a more convenient and more comprehensive solution for technical support needs. - March 22, 2008 - AnaSpec, EGT Group